Explorer
All about new medicine for Coronavirus developed by INMAS, lab of DRDO
The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) for emergency use, the Defence Ministry has said.
An anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
India
NDRF Teams Carry Out Rescue Operations As Yamuna Floods Delhi’s Monastery Market
Yamuna Floods Submerge Delhi’s ISBT Police Station, Traffic And Local Areas Hit
Big Relief Before Diwali: Govt Cuts GST Slabs To Make Daily Essentials Cheaper For Common Man
Nagpur Blast Horror: Explosion At Solar Explosives Plant Kills One, Injures Seventeen Workers
Flood Crisis In Delhi: Yamuna Overflows, Secretariat At Risk As Water Engulfs Key Areas
View More
Advertisement
Advertisement
Top Headlines
India
PM Modi, EU Leaders Push For Early FTA, Von Der Leyen Says 'India Has Important Role' In Ending Ukraine War
India
'Taxed Even Children's Toffees': Modi Slams Congress After GST Overhaul
India
‘Modi Chor’ Slogan By Mamata In Assembly Stokes BJP Ire Over ‘Anarchy’: ‘Trend Started By Rahul Gandhi’
Cities
‘Gaddi Chor, Vote Chor, Anti-Bengali’: Mamata Tears Into BJP Amid Assembly Ruckus — WATCH
Advertisement
Trending News
